Progyny, Inc. Provides Earnings Guidance for the Second Quarter and Full Year 2024
For the year, Revenue is now projected to be $1,230 million to $1,270 million, reflecting growth of 13% to 17%, Net income is projected to be $68.4 million to $75.4 million, or $0.68 to $0.75 per diluted share, on the basis of approximately 100 million assumed weighted-average fully diluted-shares outstanding.